Advisory Board Co (NASDAQ:ABCO)
During the Trading Day
| 50.19 |  -0.52 / -1.03% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 50.19 |  0.00 / 0.00% |
Volume: 10.4K |
Latest ABCO News | Press Releases
| ABCO Posts Solid 4Q and FY2013 Earnings - Analyst Blog May 13 / Zacks.com | Advisory Board Beats on Both Top and Bottom Lines May 10 / MotleyFool.com |
Today’s Trading
| Previous close | 50.71 |
| Today’s open | 50.19 |
| Day’s range | 50.02 - 50.99 |
| Volume | 208,850 |
| Average volume (3 months) | 297,211 |
| Market cap | $1.8B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +18.58% |
| Earnings growth (this year) | +5.84% |
| Earnings growth (next 5 years) | +18.50% |
| Revenue growth (last year) | +27.60% |
| P/E ratio | 82.3 |
| Price/Sales | 3.93 |
| Price/Book | 7.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALNYAlnylam Pharmaceutic... | +0.22 | +0.79% |
| ICLRICON PLC | +0.29 | +0.88% |
| CRLCharles River Labora... | +0.33 | +0.75% |
| ISISIsis Pharmaceuticals... | +0.25 | +1.23% |
Data as of 4:03pm ET, 05/23/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | $0.29 |
| Annual revenue (last year) | $370.3M |
| Annual profit (last year) | $23.1M |
| Net profit margin | 6.17% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
Chairman & Chief Executive Officer Robert W. Musslewhite |
President & Director David L. Felsenthal, MBA |
Corporate headquarters Washington, District Of Columbia |
Forecasts
